MeSH term
Frequency | Condition_Probility | Aged | 5 | 0.0 |
Humans | 31 | 0.0 |
Time Factors | 3 | 0.0 |
Adult | 15 | 0.0 |
Alleles | 4 | 0.0 |
Case-Control Studies | 5 | 0.0 |
China | 2 | 0.0 |
Female | 18 | 0.0 |
Gene Frequency | 10 | 0.0 |
Genotype | 16 | 0.0 |
Male | 18 | 0.0 |
Polymorphism, Single Nucleotide | 3 | 0.0 |
Receptors, Opioid, delta/*genetics | 2 | 66.0 |
Asian Continental Ancestry Group/genetics | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 3 | 0.0 |
Genetic Screening | 3 | 0.0 |
Phenotype | 5 | 0.0 |
Receptors, Opioid, mu/*genetics | 15 | 78.0 |
Research Support, Non-U.S. Gov't | 16 | 0.0 |
Variation (Genetics)/*genetics | 2 | 0.0 |
Alcoholism/*genetics | 4 | 4.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
*Polymorphism, Genetic | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Smoking | 2 | 0.0 |
Substance-Related Disorders/genetics | 3 | 33.0 |
Animals | 4 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Comparative Study | 8 | 0.0 |
Middle Aged | 12 | 0.0 |
Substance-Related Disorders/*genetics | 3 | 18.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Polymorphism, Genetic/genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Genetics, Population | 2 | 0.0 |
Haplotypes | 4 | 0.0 |
Linkage Disequilibrium | 3 | 0.0 |
Chi-Square Distribution | 2 | 0.0 |
Confidence Intervals | 2 | 0.0 |
Gene Frequency/genetics | 3 | 0.0 |
Odds Ratio | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Exons | 3 | 0.0 |
Mice | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Asparagine/genetics | 2 | 5.0 |
Aspartic Acid/genetics | 2 | 3.0 |
Receptors, Muscarinic/*immunology | 2 | 100.0 |
Receptors, Opioid, mu/antagonists & inhibitors/*genetics/physiology | 2 | 100.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
